New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic <scp>COVID</scp>‐19 After Complete Vaccination
Luigi Angelo Vaira, Andrea De Vito, Jérôme R. Lechien, Carlos M. Chiesa‐Estomba, Miguel Mayo‐Yáñez, Christian Calvo‐Henríquez, Sven Saussez, Giordano Madeddu, Sergio Babudieri, Paolo Boscolo‐Rizzo, Claire Hopkins, Giacomo De Riu
Abstract
The aim of this study is to investigate the clinical profile of patients who developed coronavirus disease 2019 (COVID-19) after full vaccination. Demographic, epidemiological and clinical data were collected through medical records and online patient-reported outcome questionnaire from patients who developed symptomatic SARS-CoV-2 infection, confirmed by nasopharyngeal swab, at least 2 weeks after completion of vaccination. A total of 153 subjects were included. The most frequent symptoms were: asthenia (82.4%), chemosensory dysfunction (63.4%), headache (59.5%), runny nose (58.2%), muscle pain (54.9%), loss of appetite (54.3%), and nasal obstruction (51.6%). Particularly, 62.3% and 53.6% of subjects reported olfactory and gustatory dysfunction, respectively. Symptom severity was mild or moderate in almost all cases. Chemosensory dysfunctions have been observed to be a frequent symptom even in subjects who contracted the infection after full vaccination. For this reason, the sudden loss of smell and taste could continue to represent a useful and specific diagnostic marker to raise the suspicion of COVID-19 even in vaccinated subjects. In the future, it will be necessary to establish what the recovery rate is in these patients. LEVEL OF EVIDENCE: 4 Laryngoscope, 132:419-421, 2022.